NovAccess Global Inc.
XSNX
|
PNK
|
0 Sledující
Company Quality
Profitability Score
12/100
Solvency Score
5/100
Dividends
Dividends data currently unavailable.Earnings
10/29/2025
in 135 days
-
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.
CEO
3
Zaměstnanci
Chesterland
Centrála
US
Země
Key Metrics TTM
Valuation
Market cap.
$19KEnterprise Value
$2.1MPrice to Earnings
-0.13Price to Sales
0.00Price to Book
-0.0022Price to Cash Flow
-0.12Profitability
Return on Assets
-45.82%Return on Equity
1.82%Return on Invested Capital
-12.96%Gross Margin
0.00%Operating Margin
0.00%Net Margin
0.00%Liquidity
Quick Ratio
0.0067Current Ratio
0.0067Cash Ratio
0.0001Inventory Turnover
0.00Asset Turnover
0.00Total Liabilities
$7.7MSolvency
Debt to Assets
7.66Debt to Equity
N/AInterest Coverage
-2.21Equity Ratio
-27.14Long-term Debt to Cap.
0.00Altman Z-Score
-400.3Performance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.